COVID-19 vaccination in Russia

Last updated


COVID-19 vaccination in Russia
Russia map of fully vaccinated people by percentage of population by Federal Subject as of 23rd of June 2021.png
Map of Russia by federal subject. Percentage of people fully vaccinated from the population as of 25 September 2021. [1]
Date5 December 2020 (2020-12-05) [2] – present
Location Russia
Cause COVID-19 pandemic in Russia
TargetImmunization against COVID-19
Participants52,943,693 people have received at least one dose (25 October 2021) [3]
46,768,678 people have been fully vaccinated (25 October 2021) [3]
Outcome36.3% of the Russian population has received at least one dose of a vaccine [lower-alpha 1] [3] [4]
Website вакцина.стопкоронавирус.рф

The COVID-19 vaccination campaign in Russia is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Mass vaccinations began in December 2020, starting with primarily doctors, medical workers and teachers, and in January 2021, this was extended to the entire population. [5] [6]

As of 25 October 2021, 52.9 million people have received at least one dose, with 46.8 million people fully vaccinated. [3] [7] [4]


On 11 August 2020, President Putin said in a meeting that the Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against the coronavirus to be registered. He said that one of his daughters was vaccinated. [8] The previous day, the Association of Clinical Research Organisations, a union of pharmaceutical companies in Russia, urged the head of the Ministry of Health to delay the registration due to incomplete testing. [9] The head of the Russian Direct Investment Fund (RDIF) stated that 20 countries had requested in total 1 billion doses of the vaccine, nicknamed Sputnik V. [10] On August 20 registration was called "conditional" with final registration depends on results of Phase 3 trial, [11] such registration is limited and allowed by Decree 441 for medicines in emergency situations. [12]

On 8 September 2020, the health ministry's press service said that the first batches of the vaccine developed by the Gamaleya Centre had entered civilian circulation. [13]

On 14 October 2020, President Vladimir Putin announced that the EpiVacCorona vaccine was approved. [14] Registration is limited ("on conditions") and regulated by Decree 441 for emergency use. [15] [16]

On 20 February 2021, President Vladimir Putin announced that the CoviVac vaccine was approved. [17] Registration is limited ("on conditions") too and regulated by Decree 441 for emergency situation. [15] [16]

On 6 May 2021, Sputnik Light vaccine was approved. [18]

Vaccines on order

VaccineEmergency Use Approval [16] DeploymentFinal Approval
Sputnik V Green check.svg 10 August 2020 [19] Green check.svg 27 November 2020 [20] Dark Red x.svg No
EpiVacCorona Green check.svg 14 October 2020 [14] Green check.svg 18 January 2021 [21] Dark Red x.svg No
CoviVac Green check.svg 20 February 2021 [17] Green check.svg 25 March 2021 [22] Dark Red x.svg No
Sputnik Light Green check.svg 6 May 2021 [18] Dark Red x.svg Not yetDark Red x.svg No


December 2020

Mobile vaccination point near the shopping center. Tyumen, May 2021. Movebla vakcinejo apud la acetcentro Premier (Tjumeno) 01.jpg
Mobile vaccination point near the shopping center. Tyumen, May 2021.

On 2 December 2020, President Putin ordered the start of mass vaccination of the population for the next week, starting with doctors, medical workers and teachers. [5] On 5 December, vaccinations began in Moscow. [23]

On 10 December 2020, Deputy Prime Minister Tatyana Golikova announced that approximately 6.9 million doses of the Sputnik V vaccine will enter civilian circulation in Russia before the end of February 2021. [24] On December 15, the Ministry of Health announced the start of mass vaccination in all regions. [25]

January 2021

On 6 January 2021, the RDIF announced that 1 million people had been vaccinated with the Sputnik V vaccine. On January 10, 2021, the RDIF stated that over 1.5 million people had been vaccinated. [26]

February 2021

By 17 February 2021, 2.2 million people had received the first dose of the Sputnik V vaccine and another 1.7 million people had received both doses. [27]

March 2021

By 15 March 2021, over 3.5 million people had received both doses of the Sputnik V vaccine, according to the RDIF. [28]

April 2021

On 9 April 2021, Prime Minister Mikhail Mishustin said that less than half of those vaccinated were over the age of 60. [29]

On 14 April 2021, Moscow Mayor Sergei Sobyanin said that around 820,000 Muscovites had been fully vaccinated, out of a population of 12 million. Sobyanin also said that Moscow was "fully supplied" with vaccines and urged Muscovites to get vaccinated. By 14 April, an estimated 9.5 million Russians had received at least one vaccine dose, with around 5.6 million having received both doses. [30]

On 25 April 2021, Sobyanin announced that those over the age of 60 who get vaccinated would be eligible to receive a gift card worth 1,000 rubles to spend in shops, raised through contributions from businesses, in an effort to incentivize the vaccination campaign. [31] [32]

On 26 April 2021, 11.9 million people overall had received at least a first dose of a vaccine, representing 10% of the adult population. [32]

May 2021

On 21 May 2021, Mayor of Moscow Sobyanin decried low demand for vaccines, despite free and easy access to them since January. In a meeting, he said: "It's a shame that we have not had any restrictions on vaccinations for six months and we were the first in the world to launch a mass vaccination campaign... Unfortunately, we still have 9,000 Muscovites in hospitals with severe cases of coronavirus... People are still dying, yet don't want to get vaccinated". Sobyanin also stated that the percentage of people vaccinated in Moscow was less than in any other European city. [33] [34]

June 2021

On 16 June 2021, Sobyanin announced that Moscow would introduce mandatory vaccinations for service workers in the city, following a surge in cases in the city. Business operating in service sectors would be required to have at least 60% of their workforce vaccinated with a first dose by 15 July, with both doses by 15 August. [35]

On 22 June 2021, Sobyanin announced that, beginning 28 June, restaurants, bars and cafes in Moscow would be restricted to those who can show they have been vaccinated, had the virus confirmed within the last six months, or tested negative in the last three days. [36] By 22 June, compulsory vaccinations were also decided in a number of other regions aside from Moscow and Moscow Oblast, including the city of St. Petersburg, the Sakha Republic, the Nenets Autonomous Okrug, the Leningrad, Tula, Kemerovo, Sakhalin and Tver oblasts, and Krasnodar Krai. Kremlin spokesman Dmitry Peskov also stated that discrimination against the unvaccinated was inevitable. [37]

July 2021

By 2 July 2021, compulsory vaccinations were introduced in a total of 24 federal subjects, with compulsory vaccinations planned to be introduced in Crimea and Murmansk Oblast. [38]

August 2021

September 2021

October 2021

Public opinion

Public scepticism of being vaccinated remains high. [30] A poll by the Levada Center released on 1 March 2021 found that 62% of Russian respondents did not want to receive the country's Sputnik V vaccine, with younger respondents being more reluctant. [39] Another poll by the Levada Center released on 12 May found that 62% of Russian respondents were not ready to get vaccinated with Sputnik V, with 75% of respondents aged 18-24 years old not ready compared to 47% for those over 55 years of age. [40] A survey by the job portal published on 16 May found that 42% of Russian respondents would not get vaccinated under any circumstances. [41] Public scepticism continues to exist despite Russian and Western sources detailing the positive efficacy of the vaccine. [42] A study in 2017 indicated that anti-vaccine views had been present in Russia prior to the pandemic, which only increased after the pandemic emerged. [43]

See also


  1. Including the disputed Crimea.

Related Research Articles

Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company. It is the world's largest manufacturer of vaccines located in the city of Pune, India and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries.

COVID-19 pandemic in Russia Ongoing COVID-19 viral pandemic in Russia

The COVID-19 pandemic in Russia is part of the ongoing pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have spread to Russia on 31 January 2020, when two Chinese citizens in Tyumen (Siberia) and Chita tested positive for the virus, with both cases being contained. Early prevention measures included restricting the border with China and extensive testing. The infection spread from Italy on 2 March, leading to additional measures such as cancelling events, closing schools, theatres, and museums, as well as shutting the border and declaring a non-working period which, after two extensions, lasted until 11 May 2020. By the end of March 2020, the vast majority of federal subjects, including Moscow, had imposed lockdowns. By 17 April 2020, cases had been confirmed in all federal subjects. At the beginning of September 2020, the number of COVID-19 cases in Russia reached a million. The number of COVID-19 cases in the country also reached two million on 19 November 2020, three million on 26 December 2020, four million on 10 February 2021, five million on 23 May 2021, six million on 20 July 2021 and seven million on 5 September 2021. At the end of 2020, there were nearly 3.2 million COVID-19 cases in Russia. On 3 April 2021, the number of COVID-19 deaths in the country reached 100,000. Several months later, on 22 September 2021, the number of COVID-19 deaths in Russia reached 200,000.

There are no confirmed cases of COVID-19 in Turkmenistan with the totalitarian government being proactive in censoring relevant information. It is however expected to have spread in the country unreported; specifics are difficult to ascertain and confirm in absence of independent media.

Sputnik V COVID-19 vaccine Vaccine against COVID-19

Sputnik V or Gam-COVID-Vac is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.

The Gamaleya Research Institute of Epidemiology and Microbiology, previously the N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology, is a Russian medical-research institute within the Ministry of Health of the Russian Federation.

CoronaVac Vaccine against COVID-19

CoronaVac, also known as the Sinovac COVID-19 vaccine, is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was Phase III clinical trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to BBIBP-CorV and Covaxin, other inactivated-virus COVID-19 vaccines. CoronaVac does not need to be frozen and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), temperatures at which flu vaccines are kept.

COVID-19 vaccination in Bulgaria Plan to immunize against COVID-19

The COVID-19 vaccination in Bulgaria is an immunization campaign currently taking place against SARS-CoV-2, the virus that is the cause of the COVID-19 disease. It began on 27 December 2020, in line with most other countries in the EU, and is in response to the ongoing pandemic in Bulgaria. The vaccination drive was affected by organizational and supply-related issues during the initial months while since the spring of 2021 vaccine hesitancy has contributed significantly to the country having the lowest rate of inoculations in the EU, with 20% of Bulgaria's adult citizens fully vaccinated by early September.

COVID-19 vaccination in India Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 27 October 2021, India has administered over 1.04 billion doses overall, including first and second doses of the currently-approved vaccines. In India, nearly half the eligible population has got at least one shot, and 19 per cent received both nine months after the vaccine rollout.

EpiVacCorona EpiVacCorona vaccine against COVID-19

EpiVacCorona is a peptide-based vaccine against COVID-19 developed by the VECTOR center of Virology. It consists of three chemically synthesized peptides that are conjugated to a large carrier protein. This protein is a fusion product of a viral nucleocapsid protein and a bacterial MBP protein. The third phase of a clinical trial, which should show whether the vaccine is able to protect people from COVID-19 or not, was launched in November 2020 with more than three thousand participants.

COVID-19 vaccination in Albania

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

R-Pharm is an international pharmaceutical company headquartered in Russia. It reached the headlines in 2020 following approval of its drug 'Coronavir' as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017.

On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

QazCovid-in Vaccine candidate against COVID-19

QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P is a second COVID-19 vaccine developed by the Kazakh Biosafety Research Institute and in clinical trials.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. Sinopharm COVID-19 vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021.

Sputnik Light Vaccine against COVID-19

Sputnik Light is a single dose COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector, and it can be stored at a normal refrigerator temperature of 2–8 °C (36–46 °F). The institute says this version would be ideally suited for areas with acute outbreaks, allowing more people to be vaccinated quickly. It will also be used as a third (booster) dose for those who received Sputnik V at least 6 months earlier.

COVID-19 vaccination in Kazakhstan Plan to immunize against COVID-19

COVID-19 vaccination in Kazakhstan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Ukraine

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.


  1. Russia COVID- 19 Vaccine Tracker: Federal Subjects Map. By George Karabassis. Press the 1M button in the lower right corner of the map and the 2x button to create the shown map.
  2. "Coronavirus: Russia rolls out COVID vaccination in Moscow". 5 December 2020.
  3. 1 2 3 4 "Статистика вакцинации от коронавируса".
  4. 1 2 Ritchie, Hannah; Ortiz-Ospina, Esteban; Beltekian, Diana; Mathieu, Edouard; Hasell, Joe; MacDonald, Bobbie; Giattino, Charlie; Appel, Cameron; Rodés-Guirao, Lucas; Roser, Max (5 March 2020). "Coronavirus (COVID-19) Vaccinations". Our World in Data.
  5. 1 2 "Путин поручил начать массовую вакцинацию от COVID на следующей неделе". Interfax. 2 December 2020.
  6. "Путин поручил начать массовую вакцинацию от коронавируса". Kommersant. 13 January 2021.
  7. "Russia". Reuters.
  8. "Путин объявил о регистрации вакцины от коронавируса в России".
  9. "Путин объявил о регистрации в РФ вакцины вопреки мнению экспертов".
  10. "Россия получила запрос на 1 млрд доз вакцины против коронавируса". 2020-08-11.
  11. Corum, Jonathan; Zimmer, Carl (May 7, 2021). "How Gamaleya's Vaccine Works". The New York Times. Retrieved 8 June 2021. Russia .. saying the vaccine approval was a “conditional registration certificate”
  12. "The first vaccine that wasn't Russia approves a coronavirus immunization, but a lack of clinical trials means those getting inoculated are rolling the dice". Meduza. August 12, 2020. Retrieved 8 June 2021. provisional approval was issued under conditions established by Government Decree 441
  13. "Первую партию российской вакцины от COVID выпустили в гражданский оборот".
  14. 1 2 "Совещание с членами Правительства". President of Russia. 14 October 2020.
  15. 1 2 "Вакцина "КовиВак" поступила в регионы. Чем она отличается от других". РБК (in Russian). 2021-06-01. Retrieved 8 June 2021. регистрация была выдана «на условиях», определенных постановлением правительства (№ 441)
  16. 1 2 3 Every vaccine instruction includes notice: "Данный лекарственный препарат зарегистрирован по процедуре регистрации препаратов, предназначенных для применения в условиях угрозы возникновения, возникновения и ликвидации чрезвычайных ситуаций. Инструкция подготовлена на основании ограниченного объема клинических данных по применению препарата и будет дополняться по мере поступления новых данных. ... данный лекарственный препарат зарегистрирован по особой процедуре регистрации, в связи, с чем необходимо уведомлять Федеральную службу по надзору в сфере здравоохранения о каждом факте применения лекарственного препарата, путем внесения информации в соответствующей раздел информационной системы ЕГИСЗ" (drug is registered for use ... in case of emergency... Each usage of drug must be registered into information system EGISZ. Sputnik-v EUA notice in instruction; News article mentions epivaccorona EUA registration; CoviVac instruction with EUA notice
  17. 1 2 Ivanova, Polina (2021-02-20). "Russia approves its third COVID-19 vaccine, CoviVac". Reuters. Retrieved 2021-03-13.
  18. 1 2 "Russia Approves Single-Dose Sputnik Light Covid Vaccine For Use". NDTV Coronavirus. 6 May 2021.
  19. Callaway E (August 2020). "Russia's fast-track coronavirus vaccine draws outrage over safety". Nature. 584 (7821): 334–335. doi: 10.1038/d41586-020-02386-2 . PMID   32782400. This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.
  20. "Russian Military Launches Coronavirus Vaccination Campaign". The Moscow Times. November 27, 2020.
  21. "Mass coronavirus vaccination campaign begins in Russia". Russian News Agency. January 18, 2021. Retrieved April 1, 2021.
  22. "COVID-вакцина центра имени Чумакова вышла в гражданский оборот" (in Russian). Interfax. March 25, 2021. Retrieved May 2, 2021.
  23. "Covid: Russia begins vaccinations in Moscow". BBC News. 5 December 2020.
  24. "About 6.9 mln doses of Sputnik V vaccine to enter circulation in Russia by end of February". TASS. 10 December 2020.
  25. "Минздрав объявил о старте вакцинации от COVID-19 во всех регионах РФ". Interfax. 15 December 2020.
  26. ""Спутником V" привили более 1,5 млн человек". Interfax. 10 January 2021.
  27. "В России привились "Спутником V" 3,9 млн человек". 17 February 2021.
  28. "В России 3,5 миллиона человек полностью привились от COVID-19". 15 March 2021.
  29. "Мишустин потребовал снизить риски завоза в Россию новых штаммов коронвируса". Interfax. 9 April 2021.
  30. 1 2 "Less Than 10% of People Vaccinated In Moscow, Center of Russia's Vaccination Drive". The Moscow Times. 15 April 2021.
  31. "Миллион призов. Программа поощрения вакцинации для старшего поколения". 25 April 2021.
  32. 1 2 "Russia Has Vaccinated 10% of Its Adult Population". The Moscow Times. 26 April 2021.
  33. "Moscow's Coronavirus Vaccination Rate Lower Than Any Other European City, Mayor Says". The Moscow Times. 21 May 2021.
  34. "Moscow Mayor decries low demand for COVID-19 vaccines". Reuters. 21 May 2021.
  35. "Moscow Orders Mandatory Vaccinations for Service Workers as Covid-19 Cases Surge". The Moscow Times. 16 June 2021.
  36. "Moscow to require anti-Covid pass to enter bars, restaurants as cases surge". France24. 22 June 2021.
  37. "Песков заявил о неминуемой дискриминации непривившихся". Kommersant. 22 June 2021.
  38. "Обязательная вакцинация от коронавируса в каких регионах". 2 July 2021.
  39. "Over 60% of Russians don't want Sputnik V vaccine, see coronavirus as biological weapon: Reuters poll". Reuters. 1 March 2021.
  40. "КОРОНАВИРУС И ВАКЦИНА". Levada Center. 12 May 2021.
  41. "Каждый пятый россиянин готов привиться от коронавируса ради поездки за границу". 16 May 2021.
  42. "Russia's Vaccine Is Safe and Effective, Published Study Shows". New York Times. 2 February 2021.